Key result
Percutaneous pulmonary valve implantation is a safe and effective treatment for right ventricular outflow tract dysfunction in patients with congenital heart disease.
Why the study?
Most patients with congenital heart disease and right ventricle outflow tract dysfunction require sequential pulmonary valve replacements, but anatomical variations can limit procedural success with percutaneous pulmonary valve implantation.
Population
Patients with congenital heart disease with right ventricle outflow tract dysfunction
Design
Review
Authors
Loading...
May support use in congenital heart disease; leaves open need for randomized confirmation.
Percutaneous pulmonary valve implantation is a safe and effective procedure for patients with congenital heart disease and RVOT dysfunction, though anatomical variations remain a challenge.
Driesen et al. (2019) conducted a review in Congenital heart disease with right ventricle outflow tract (RVOT) dysfunction. Percutaneous pulmonary valve implantation (PPVI) was evaluated. Percutaneous pulmonary valve implantation is a safe and effective treatment for right ventricular outflow tract dysfunction in patients with congenital heart disease.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: